Lion Point Capital, LP
Net seller this quarter
$20.9M
35
-$647K
55.0%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 CUE | $1.67M | 7.99% | 1.01% | -27.9% | Q4 2025 |
 PRAX | $1.49M | 7.13% | 0.02% | Not reported | Q3 2025 |
 MLTX | $1.31M | 6.29% | 0.09% | Not reported | Q3 2025 |
 FENC | $1.21M | 5.78% | 0.32% | Not reported | Q2 2023 |
 RPRX | $1.2M | 5.74% | 0.01% | Not reported | Q3 2025 |
 CMPS | $1.13M | 5.41% | 0.06% | Not reported | Q3 2025 |
 MIST | $1.1M | 5.26% | 0.66% | Not reported | Q1 2022 |
 BNTC | $830K | 3.97% | 0.18% | Not reported | Q3 2024 |
 SNDX | $787K | 3.76% | 0.04% | Not reported | Q2 2023 |
 BHVN | $769K | 3.68% | 0.03% | Not reported | Q3 2024 |
 GERN | $740K | 3.54% | 0.09% | Not reported | Q1 2024 |
 QURE | $677K | 3.24% | 0.02% | Not reported | Q4 2025 |
 ARDX | $656K | 3.14% | 0.05% | Not reported | Q3 2022 |
 LNTH | $610K | 2.92% | 0.01% | Not reported | Q4 2025 |
 IRON | $592K | 2.83% | 0.02% | Not reported | Q3 2024 |
 SRPT | $512K | 2.45% | 0.03% | Not reported | Q4 2025 |
 HUMA | $507K | 2.43% | 0.23% | Not reported | Q3 2023 |
 KURA | $505K | 2.41% | 0.05% | Not reported | Q3 2025 |
 VTRS | $440K | 2.10% | 0.00% | Not reported | Q4 2025 |
 DYN | $400K | 1.91% | 0.01% | Not reported | Q4 2025 |
 BBIO | $372K | 1.78% | 0.00% | Not reported | Q2 2024 |
 EWTX | $370K | 1.77% | 0.01% | Not reported | Q4 2025 |
 PCRX | $342K | 1.64% | 0.03% | Not reported | Q4 2025 |
 RGNX | $319K | 1.52% | 0.05% | Not reported | Q1 2024 |
 RCKT | $294K | 1.41% | 0.08% | Not reported | Q3 2025 |
 JANX | $292K | 1.40% | 0.03% | Not reported | Q4 2025 |
 MLYS | $283K | 1.36% | 0.01% | Not reported | Q1 2024 |
 GHRS | $274K | 1.31% | 0.02% | Not reported | Q4 2025 |
 MCRB | $249K | 1.19% | 0.32% | Not reported | Q3 2021 |
 AZTA | $248K | 1.18% | 0.02% | Not reported | Q4 2025 |
 JSPR | $196K | 0.94% | 1.66% | Not reported | Q1 2024 |
 INVA | $186K | 0.89% | 0.01% | Not reported | Q4 2025 |
 IPHA | $149K | 0.71% | 0.09% | Not reported | Q4 2025 |
 ARQT | $138K | 0.66% | 0.00% | Not reported | Q3 2024 |
 SPRB | $54K | 0.26% | 0.04% | Not reported | Q1 2024 |
| Q1 2026 | |||||
| PRAX | $1.43M | 8.57% | 0.02% | Not reported | Q3 2025 |
| MLTX | $1.26M | 7.52% | 0.13% | Not reported | Q3 2025 |
| RPRX | $1.03M | 6.14% | 0.01% | Not reported | Q3 2025 |
| MIST | $976K | 5.83% | 0.70% | +8.6% | Q1 2022 |
| GERN | $861K | 5.15% | 0.09% | Not reported | Q1 2024 |
| SNDX | $841K | 5.03% | 0.04% | Not reported | Q2 2023 |
| ARDX | $771K | 4.61% | 0.05% | Not reported | Q3 2022 |
| FENC | $691K | 4.13% | 0.33% | Not reported | Q2 2023 |
| BNTC | $660K | 3.95% | 0.18% | Not reported | Q3 2024 |
| SRPT | $620K | 3.71% | 0.03% | Not reported | Q4 2025 |
| IRON | $518K | 3.10% | 0.02% | Not reported | Q3 2024 |
| CUE | $506K | 3.03% | 67.67% | Not reported | Q4 2025 |
| CMPS | $442K | 2.64% | 0.06% | +37.9% | Q3 2025 |
| BHVN | $437K | 2.61% | 0.03% | Not reported | Q3 2024 |
| LNTH | $417K | 2.49% | 0.01% | Not reported | Q4 2025 |
| JSPR | $407K | 2.44% | 1.66% | Not reported | Q1 2024 |
| HUMA | $394K | 2.36% | 0.29% | +30.0% | Q3 2023 |
| VTRS | $374K | 2.24% | 0.00% | Not reported | Q4 2025 |
| KURA | $374K | 2.24% | 0.05% | Not reported | Q3 2025 |
| BBIO | $371K | 2.22% | 0.00% | Not reported | Q2 2024 |
| DYN | $326K | 1.95% | 0.01% | Not reported | Q4 2025 |
| RCKT | $308K | 1.84% | 0.08% | Not reported | Q3 2025 |
| PCRX | $305K | 1.82% | 0.03% | Not reported | Q4 2025 |
| EWTX | $287K | 1.71% | 0.01% | Not reported | Q4 2025 |
| MLYS | $284K | 1.70% | 0.01% | Not reported | Q1 2024 |
| MCRB | $280K | 1.67% | 0.33% | Not reported | Q3 2021 |
| JANX | $264K | 1.58% | 0.03% | Not reported | Q4 2025 |
| QURE | $240K | 1.44% | 0.02% | Not reported | Q4 2025 |
| RGNX | $223K | 1.33% | 0.05% | Not reported | Q1 2024 |
| AZTA | $205K | 1.22% | 0.02% | Not reported | Q4 2025 |
| INVA | $191K | 1.14% | 0.01% | Not reported | Q4 2025 |
| GHRS | $143K | 0.86% | 0.02% | Not reported | Q4 2025 |
| ARQT | $124K | 0.74% | 0.00% | Not reported | Q3 2024 |
| IPHA | $104K | 0.62% | 0.09% | Not reported | Q4 2025 |
| SPRB | $65.4K | 0.39% | 0.07% | Not reported | Q1 2024 |
| Q4 2025 | |||||
| MIST | $1.53M | 7.89% | 0.71% | +14.7% | Q1 2022 |
| PRAX | $1.31M | 6.79% | 0.02% | -21.9% | Q3 2025 |
| MLTX | $890K | 4.60% | 0.13% | Not reported | Q3 2025 |
| FENC | $866K | 4.48% | 0.33% | -8.6% | Q2 2023 |
| JSPR | $851K | 4.40% | 1.66% | +16.7% | Q1 2024 |
| BNTC | $835K | 4.32% | 0.18% | Not reported | Q3 2024 |
| RPRX | $827K | 4.28% | 0.01% | Not reported | Q3 2025 |
| GERN | $763K | 3.95% | 0.09% | +15.6% | Q1 2024 |
| SNDX | $756K | 3.91% | 0.04% | -34.6% | Q2 2023 |
| ARDX | $750K | 3.88% | 0.05% | -21.0% | Q3 2022 |
| CUE | $673K | 3.48% | 68.40% | New | Q4 2025 |
| IRON | $643K | 3.33% | 0.02% | -23.6% | Q3 2024 |
| SRPT | $613K | 3.17% | 0.03% | New | Q4 2025 |
| BHVN | $584K | 3.02% | 0.04% | +127.8% | Q3 2024 |
| HUMA | $480K | 2.49% | 0.26% | +498.8% | Q3 2023 |
| KURA | $478K | 2.47% | 0.05% | Not reported | Q3 2025 |
| MCRB | $470K | 2.43% | 0.33% | +16.3% | Q3 2021 |
| CMPS | $400K | 2.07% | 0.06% | Not reported | Q3 2025 |
| DAWN | $391K | 2.03% | 0.04% | Not reported | Q3 2025 |
| RGNX | $383K | 1.98% | 0.05% | -53.9% | Q1 2024 |
| BBIO | $382K | 1.98% | 0.00% | -62.4% | Q2 2024 |
| MLYS | $381K | 1.97% | 0.01% | -73.1% | Q1 2024 |
| VTYX | $375K | 1.94% | 0.06% | New | Q4 2025 |
| LNTH | $366K | 1.89% | 0.01% | New | Q4 2025 |
| DYN | $352K | 1.82% | 0.01% | New | Q4 2025 |
| QURE | $352K | 1.82% | 0.02% | New | Q4 2025 |
| PCRX | $349K | 1.81% | 0.03% | New | Q4 2025 |
| VTRS | $345K | 1.78% | 0.00% | New | Q4 2025 |
| AZTA | $323K | 1.67% | 0.02% | New | Q4 2025 |
| RCKT | $302K | 1.56% | 0.08% | Not reported | Q3 2025 |
| JANX | $262K | 1.36% | 0.03% | New | Q4 2025 |
| EWTX | $226K | 1.17% | 0.01% | New | Q4 2025 |
| INVA | $164K | 0.85% | 0.01% | New | Q4 2025 |
| ARQT | $152K | 0.79% | 0.00% | -85.1% | Q3 2024 |
| IPHA | $142K | 0.73% | 0.09% | New | Q4 2025 |
 NERV | $141K | 0.73% | 0.08% | New | Q4 2025 |
| GHRS | $130K | 0.67% | 0.02% | New | Q4 2025 |
| SPRB | $87.1K | 0.45% | 0.07% | Not reported | Q1 2024 |
| MRSN | $2.89K | 0.01% | 0.00% | -99.6% | Q1 2023 |
| Q3 2025 | |||||
| MLYS | $1.48M | 8.40% | 0.05% | -50.6% | Q1 2024 |
| MIST | $1.32M | 7.48% | 0.77% | +20.0% | Q1 2022 |
| FENC | $1.15M | 6.54% | 0.44% | -37.2% | Q2 2023 |
| JSPR | $949K | 5.39% | 1.42% | +172.1% | Q1 2024 |
| AVDL | $912K | 5.18% | 0.06% | -39.5% | Q3 2023 |
 KNSA | $909K | 5.16% | Not reported | -49.0% | Q1 2020 |
 INSM | $900K | 5.11% | 0.00% | -41.3% | Q2 2022 |
| ARDX | $897K | 5.09% | 0.07% | -51.5% | Q3 2022 |
| BNTC | $870K | 4.94% | 0.24% | Not reported | Q3 2024 |
| SNDX | $846K | 4.81% | 0.06% | Not reported | Q2 2023 |
| RPRX | $755K | 4.29% | 0.01% | New | Q3 2025 |
| IRON | $700K | 3.98% | 0.03% | Not reported | Q3 2024 |
| BBIO | $691K | 3.92% | 0.01% | -48.9% | Q2 2024 |
| GERN | $685K | 3.89% | 0.08% | Not reported | Q1 2024 |
| ARQT | $665K | 3.78% | 0.03% | -23.8% | Q3 2024 |
| RGNX | $557K | 3.17% | 0.11% | Not reported | Q1 2024 |
| MCRB | $522K | 2.97% | 0.31% | +59.3% | Q3 2021 |
| MLTX | $484K | 2.75% | 0.13% | New | Q3 2025 |
| KURA | $407K | 2.31% | 0.05% | New | Q3 2025 |
| BHVN | $341K | 1.94% | 0.02% | Not reported | Q3 2024 |
| CMPS | $332K | 1.89% | 0.06% | New | Q3 2025 |
| PRAX | $302K | 1.72% | 0.03% | New | Q3 2025 |
| DAWN | $296K | 1.68% | 0.04% | New | Q3 2025 |
| RCKT | $280K | 1.59% | 0.08% | New | Q3 2025 |
| MRSN | $200K | 1.14% | 0.52% | -96.0% | Q1 2023 |
| HUMA | $145K | 0.83% | 0.05% | Not reported | Q3 2023 |
| SPRB | $8.95K | 0.05% | 0.18% | Not reported | Q1 2024 |